Eisai Co., Ltd.: all 644 studies

Page 6 of 7. Open to participants first (16), then studies with results posted, then the rest; newest registration first within each.

• A Phase 3 Trial of E7777 in Combination With CHOP Compared With CHOP Alone for the First-Line Treatment of Peripheral T-cell LymphomaWithdrawnNCT01355783Phase 3
• Efficacy and Safety of Cinitapride Tablets in the Treatment of Mild to Moderate Functional DyspepsiaCompletedNCT01355276Phase 3
• Subject Variability in Two Lots of E5501 Administered to Fed and Fasted Healthy SubjectsCompletedNCT01327872Phase 1
• Safety, Tolerability, and Efficacy of Donepezil (Aricept) in Parkinson' s Disease (PD) Patients With DementiaCompletedNCT01327859Phase 3
• Quality of Life in New Treatable Therapy as Rabeprazole Option for Refractory Reflux EsophagitisCompletedNCT01321567
• A Study to Assess the Transfer of Fospropofol and Its Active Metabolite, Propofol, to Breast Milk Following Administration of LUSEDRA to Lactating Women Undergoing a Needed ProcedureCompletedNCT01309984Phase 1
• A Study to Characterize Pharmacokinetics (PK) and Pharmacodynamics (PD) of LUSEDRA® Administered as Continuous Infusion or Bolus Compared With Continuous Infusion of Propofol Injectable EmulsionCompletedNCT01308541Phase 1
• A Clinical Study in Healthy Male Volunteers to Compare the Bioequivalence of Fixed Dose Combination of Eperisone Hydrochloride 50mg Plus Diclofenac Sodium 50mg as Capsule With Eperisone Hydrochloride 50mg and Diclofenac Sodium 50mg Tablets Under Fasting Conditions (Study 013-10)CompletedNCT01306318Not applicable
• A Clinical Trial to Study the Effects of a Fixed Dose Combination of Diclofenac and Eperisone Hydrochloride With Plain Eperisone Hydrochloride in Patients With Low Back PainCompletedNCT01300312Phase 3
• Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Subjects and an Elderly CohortCompletedNCT01294540Phase 1
• A Study to Evaluate the Relative Bioavailability and Intra-Subject Variability of Two Lots of E5501 40 mg Tablets Administered Twice as Single Oral Doses to Healthy SubjectsCompletedNCT01289509Phase 1
• A Study to Investigate Use Patterns and Safety in Simulated Actual Over-the-counter (OTC) Use of Rabeprazole Sodium for the Treatment of Heartburn SymptomsCompletedNCT01286194
• A Study to Evaluate the Safety and Efficacy of Zonisamide an Antiepileptic Drug as Monotherapy or Adjunctive Therapy in Treatment of Adult Patients With Partial, Generalized or Combined Seizures.CompletedNCT01283256
• Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter PyloriCompletedNCT01264822
• A Study to Evaluate the Effects of Diltiazem, a Moderate CYP3A4/A5 Inhibitor, on the Pharmacokinetics and Pharmacodynamics of E5555 and Its Metabolites in Healthy SubjectsCompletedNCT01261156Phase 1
• A Single-Center, Open-Label, Randomized, 3-Treatment Crossover Bioavailability Study of Single Oral Doses of E5501 Old Tablet Formulation Under Fasted Conditions and a New Tablet Formulation Under Fed and Fasted Conditions in Healthy SubjectsCompletedNCT01260155Phase 1
• E2022 Patch Formulation Single Dose Phase I StudyCompletedNCT01253434Phase 1
• Single and Multiple Dose Asian Bridging StudyCompletedNCT01251731Phase 1
• Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's DiseaseCompletedNCT01251718
• Randomized, Placebo-controlled Study to Evaluate Effects of E5555 on Renal Function Parameters and OCT2 ActivityCompletedNCT01241669Phase 1
• An Open-Label, Multi-Center, Expanded Access Program With Eribulin for the Treatment of Advanced Breast Cancer RefractoryApproved for marketingNCT01240421
• E7080 Food Effect Study in Healthy SubjectsCompletedNCT01240408Phase 1
• A Study to Demonstrate Bioequivalence Between 6 x 2 mg Tablets of Perampanel and a Single 12 mg Tablet of Perampanel in Healthy SubjectsCompletedNCT01240187Phase 1
• A Randomized, Double-blind, Placebo-controlled, Combined Single Ascending Dose and Multiple Ascending Dose StudyCompletedNCT01230853Phase 1
• A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy SubjectsCompletedNCT01221818Phase 1
• A Randomized, Double-blind, Placebo-controlled, Sequential Ascending, Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2212 in Healthy SubjectsCompletedNCT01221259Phase 1
• A Safety and MORAb-028 Dose Determination Study in Subjects With Metastatic MelanomaTerminatedNCT01212276Phase 1
• A Study to Investigate the Potential Pharmacokinetic Interaction of Perampanel With Oral Contraceptives in Healthy Female SubjectsCompletedNCT01209858Phase 1
• Exploratory Study of Farletuzumab to Treat Resectable, Non-functioning Pituitary AdenomasWithdrawnNCT01203618Phase 2
• An Study of Efficacy and Safety of ClevudineCompletedNCT01192854Phase 3
• Safety and Efficacy of Mecobalamin Injection in Peripheral Neuropathies Patients (Study JGAZSY091109)CompletedNCT01192113Phase 4
• Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric UlcerCompletedNCT01190657Phase 4
• A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Safety, Tolerability and Efficacy of E2007 in Parkinson's Disease Patients With "Wearing Off" Motor Fluctuations and "On" Period DyskinesiasCompletedNCT01172379Phase 2
• A Study to Evaluate the Effect on 24-hour, Intragastric pH of RAB ER 50-mg Capsules Compared With Esomeprazole (Nexium) 40 mg Capsules and Rabeprazole (Aciphex) 20-mg TabletsCompletedNCT01153659Phase 1
• An Evaluation Of The Efficacy And Safety Of Donepezil Hydrochloride (E2020) In Migraine ProphylaxisCompletedNCT01146509Phase 2
• Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-CompletedNCT01129596
• Safety Study of Human IgM (MORAb-028) to Treat Metastatic MelanomaTerminatedNCT01123304Phase 1
• A Pilot Cross-over Bioequivalence Study of E3810 for Healthy Japanese Male (Under Postprandial Condition)CompletedNCT01085708Phase 1
• Study of E3810 for Healthy Japanese Male (Under Fasting Condition)CompletedNCT01085695Phase 1
• Pharmacokinetics Study of Donepezil HCl in Subjects Receiving Haemodialysis.CompletedNCT01063556Phase 4
• A Study of MORAb-003 in Patients With Solid TumorCompletedNCT01049061Phase 1
• A Study of MORAb-009 in Patients With Solid TumorCompletedNCT01018784Phase 1
• Safety Study of Farletuzumab, Carboplatin and Pegylated Liposomal Doxorubicin (PLD) to Treat Platinum-sensitive Ovarian CancerCompletedNCT01004380Phase 1
• A Randomized Study of Epigenetic Priming Using Decitabine With Front Line Induction Chemotherapy Compared With Immediate Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) SubjectsWithdrawnNCT00943553Phase 2
• Escalation Study to Determine Bioavailability of a Single Oral Dose of Decitabine in Patients With Myelodysplastic Syndrome (MDS)CompletedNCT00941109Phase 1
• Evaluating the Efficacy and Safety of Oral Ranirestat (40 and 80 mg) in Mild to Moderate Diabetic Sensorimotor PolyneuropathyCompletedNCT00927914Phase 2/3
• A Study of E7050 Administered Orally to Patients With Advanced Solid TumorsCompletedNCT00921869Phase 1
• A Dose-Finding Study of E7050 Administered Orally to Patients With Advanced Solid TumorsCompletedNCT00869895Phase 1
• A Study of of MORAb-004 in Subjects With Solid TumorsCompletedNCT00847054Phase 1
• To Assess the Effect of Lorcaserin Hydrochloride on Energy Metabolism and Food IntakeCompletedNCT00829140Phase 1
• Pharmacokinetic Properties of Lorcaserin in Subjects With Hepatic ImpairmentCompletedNCT00828932Phase 1
• Pharmacokinetic Properties of Lorcaserin in the Fed and Fasted StateCompletedNCT00828724Phase 1
• Abuse Potential of Single Doses of Lorcaserin in Healthy Recreational Polydrug UsersCompletedNCT00828659Phase 1
• Pharmacokinetic Properties of Lorcaserin in Obese or Overweight Elderly SubjectsCompletedNCT00828581Phase 1
• Pharmacokinetic Properties of Lorcaserin in Subjects With Renal ImpairmentCompletedNCT00828438Phase 1
• A Phase 1, Multicenter, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of E6201 in Subjects With Advanced Solid TumorsCompletedNCT00794781Phase 1
• A Study of Eritoran (E5564) Administered IV Over 14 Days Prior to and During Bone Marrow Engraftment in BMT Patients Who Have Received Myeloablative Conditioning Treatment and Are Receiving Bone Marrow or Stem Cells From Matched Related DonorsTerminatedNCT00756912Phase 1
• Comparing The Effect On Cognition Of Adjunctive Therapy With Zonisamide Versus Sodium ValproateCompletedNCT00713622Phase 4
• Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's DiseaseWithdrawnNCT00711204Phase 4
• ZAGAL Study: Evaluating Effectiveness and Tolerability of Zonisamide as Adjunctive Therapy in Patients With Partial Onset Seizures Treated With Two Antiepileptic DrugsCompletedNCT00659958Phase 4
• A Double-Blind Study of E5555 in Japanese Patients With Acute Coronary SyndromeCompletedNCT00619164Phase 2
• Safety and Tolerability of E5555 and Its Effects on Markers of Intravascular Inflammation in Subjects With Acute Coronary SyndromeCompletedNCT00548587Phase 2
• The Effect of Vitamin K2 on Bone TurnoverCompletedNCT00548509Phase 4
• A Double-Blind Study of E5555 in Japanese Subjects With Coronary Artery DiseaseCompletedNCT00540670Phase 2
• Paired-Comparison Study Evaluating the Efficacy and Safety of E6201 Versus Vehicle for the Treatment of Plaque-Type PsoriasisCompletedNCT00539929Phase 2
• A Dose Escalation Study of E7107 Administered Intravenously on Days 1 and 8 Every 21 Days to Patients With Solid TumorsSuspendedNCT00499499Phase 1
• A Study To Evaluate The Efficacy And Safety Of Betahistine Mesilate In The Treatment Of Patients With Vertigo Caused By Cerebral Infarction In Posterior CirculationWithdrawnNCT00474409Phase 4
• A Dose Escalation Study of E7107 Administered IV (Bolus) on Days 1, 8, and 15 Every 28 Days to Patients With Solid TumoursSuspendedNCT00459823Phase 1
• The Effect Of E2007 On Pharmacodynamic Responses To Levodopa Among Patients With Parkinson's Disease Who Experience Dyskinesia And Motor FluctuationsWithdrawnNCT00451633Phase 2
• A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00445172Phase 2/3
• A Study in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00444613Phase 2/3
• Post-marketing Study of Monteplase ("Cleactor") in Patients With Acute Pulmonary EmbolismCompletedNCT00442234Phase 4
• Safety, Tolerability and Pharmacokinetics of MORAb-003 in Subjects With Advanced Ovarian CancerCompletedNCT00428766Phase 1
• Hippocampus Study: Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological MarkersCompletedNCT00403520Phase 4
• A Study of ZYC300 Administered With Cyclophosphamide Pre-DosingCompletedNCT00381173Phase 1
• Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid TumorsCompletedNCT00374660Phase 1/2
• ACCESS: A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients With Severe SepsisCompletedNCT00334828Phase 3
• Evaluation of Eperisone HCl in the Treatment of Acute Musculoskeletal Spasm Associated With Low Back Pain - A Double Blind, Randomised, Placebo Controlled Clinical TrialCompletedNCT00327730Phase 3
• A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung CancerCompletedNCT00325494Phase 1
• Safety and Tolerability of E5555 and Its Effects on Markers of Intravascular Inflammation in Subjects With Coronary Artery DiseaseCompletedNCT00312052Phase 2
• A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid TumorsCompletedNCT00309179Phase 2
• Safety and Efficacy Study for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving Stem Cell Transplantation.CompletedNCT00306735Phase 2
• An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Flexible BronchoscopyCompletedNCT00306722Phase 3
• The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)CompletedNCT00293176Phase 4
• The Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor FluctuationsCompletedNCT00286897Phase 3
• A Clinical Trial of Decitabine in Patients With Myelodysplastic SyndromeTerminatedNCT00282399Phase 1
• Study Investigating the Effect of E7337 on Tumor Like Lesions in Computed Tomography (CT) of the LiverCompletedNCT00280410Phase 2/3
• A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine CervixCompletedNCT00264732Phase 2/3
• An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During ColonoscopyCompletedNCT00261599Phase 3
• EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)CompletedNCT00230568Phase 4
• Open Label, Zonegran (Zonisamide) In Partial Onset SeizuresCompletedNCT00215592Phase 4
• A Study of ONTAK in Patients With Relapsed or Refractory, B-Cell Non Hodgkin's LymphomaCompletedNCT00211276Phase 2
• Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL)CompletedNCT00211198Phase 4
• A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Elderly Patients Undergoing Elective ColonoscopyTerminatedNCT00209599Phase 2
• A Study of AQUAVAN® Injection for Sedation in Elderly Patients Undergoing Flexible BronchoscopyTerminatedNCT00209586Phase 3
• A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective ColonoscopyCompletedNCT00209573Phase 3
• Study to Assess Safety and Efficacy of AQUAVAN® Injection for Sedation During Cardiac CatheterizationCompletedNCT00209547Phase 3
• A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective ColonoscopyCompletedNCT00209534Phase 2
• Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for Anesthesia During Coronary Artery SurgeryCompletedNCT00209521Phase 2
• 2 Year Study to Evaluate the Effects of GPI 1485 on [123I]b-CIT/SPECTScanning and Clinical Efficacy in Patients With PDCompletedNCT00209508Phase 2

← Eisai Co., Ltd. overview and focus areas